Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Tert-Butyl1-(4-Bromophenyl)cyclobutylcarbamate is a complex organic chemical compound that belongs to the carbamate class. It is characterized by a unique structure that includes a cyclobutyl ring with a carbamate functional group and a bromophenyl substituent. Tert-Butyl1-(4-Bromophenyl)cyclobutylcarbamate is composed of a tertiary butyl group, a bromophenyl group, and a cyclobutyl group, all interconnected to form its distinct molecular architecture. The properties, applications, and safety measures associated with Tert-Butyl1-(4-Bromophenyl)cyclobutylcarbamate are subject to scientific investigation and research, and its potential uses may be explored in various industries such as pharmaceuticals and agrochemicals, contingent on its reactivity and biological activity.

1032350-06-3

Post Buying Request

1032350-06-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1032350-06-3 Usage

Uses

Used in Pharmaceutical Industry:
Tert-Butyl1-(4-Bromophenyl)cyclobutylcarbamate is used as a potential active pharmaceutical ingredient for the development of new drugs. Its unique structure may offer specific reactivity and biological activity that could be harnessed for therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, Tert-Butyl1-(4-Bromophenyl)cyclobutylcarbamate may be utilized as a component in the formulation of pesticides or other crop protection products. Its chemical properties could contribute to the effectiveness of these products in managing pests and diseases in agriculture.

Check Digit Verification of cas no

The CAS Registry Mumber 1032350-06-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,2,3,5 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1032350-06:
(9*1)+(8*0)+(7*3)+(6*2)+(5*3)+(4*5)+(3*0)+(2*0)+(1*6)=83
83 % 10 = 3
So 1032350-06-3 is a valid CAS Registry Number.

1032350-06-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl (1-(4-bromophenyl)cyclobutyl)carbamate

1.2 Other means of identification

Product number -
Other names tert-butyl N-[1-(4-bromophenyl)cyclobutyl]carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1032350-06-3 SDS

1032350-06-3Downstream Products

1032350-06-3Relevant articles and documents

ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

-

Paragraph 0230; 0234; 0235; 0236; 0611; 0612; 0613, (2017/06/12)

A compound of formula (I): wherein the substituents are as defined in the description. Medicinal products containing the same which are useful in treating or preventing pathologies which are the result of activation of the RhoA/ROCK pathway and phosphorylation of the myosin light chain.

General and cost-effective synthesis of 1-heteroaryl/arylcycloalkylamines and their broad applications

Zhang, Dehui,Zheng, Hongchao,Wang, Xiaodong

, p. 1941 - 1953 (2016/04/05)

A general and cost-effective route has been developed to synthesize 1-heteroarylsubstituted cycloalkylamines from readily available heteroarylacetate in good yields. This synthesis features a LHMDS promoted cyclization and one-pot hydrolysis/Curtius rearr

ANTITUMOR EFFECT POTENTIATOR COMPOSED OF IMIDAZOOXAZINE COMPOUND

-

, (2015/05/19)

An antitumor effect potentiator for potentiating one or more other antitumor agents, comprising, as an active ingredient, an imidazooxazine compound represented by Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, B, C, and D represen

PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE

-

, (2015/11/03)

The present invention is directed to a processes for the synthesis of 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine:

NOVEL IMIDAZO-OXAZINE COMPOUND OR SALT THEREOF

-

, (2014/02/15)

The present invention provides an imidazooxazine compound represented by Formula (I) or a salt thereof, wherein A, B, C, and D are as defined in the specification.

SUBSTITUTED IMIDAZOPYRAZINES AS AKT KINASE INHIBITORS

-

Page/Page column 48, (2013/07/25)

Compounds of formula (I) which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

SUBSTITUTED PYRAZOLOPYRIMIDINES AS AKT KINASE INHIBITORS

-

Page/Page column 47, (2013/07/25)

Compounds of formula (I) which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

BICYCLIC PYRIMIDINES

-

, (2012/02/02)

Compounds of formula (I), which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

IMIDAZOPYRIDAZINES AS AKT KINASE INHIBITORS

-

, (2012/10/18)

Imidazopyridazines of formula (I) a process for their production and the use thereof.

SUBSTITUTED IMIDAZO[1,2-A]PYRIMIDINES AND -PYRIDINES

-

Page/Page column 86, (2012/02/02)

Compounds of formula (I) which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1032350-06-3